Ensysce Biosciences (ENSC) Director Resigns From Board
Published on 4/3/2026

AI Summary
Summarized by AI from the source belowEnsysce Biosciences (ENSC) announced the resignation of director Curtis Rosebraugh from its board. This departure could result in a shift in corporate governance and strategy. The company did not provide specific reasons for the resignation or any immediate impact on operations. The resignation of a board member can affect investor confidence and market perception of the company’s leadership.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Markets
Berkshire Hathaway (BRKA) Holds Nearly $400 Billion in Cash
Jul 4

Markets
Chevron (CVX) vs. Exxon Mobil (XOM) Analysis for Investors in 2026
Jul 4

Markets
Rivian (RIVN) Raises 2026 Delivery Outlook to 65,000-70,000 Units
Jul 4

Markets
Micron (MU) Stock Rises 698% in a Year Amid Speculation on Split
Jul 4